We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Simple Contrast Ultrasound Scan Overcomes MR and CT Limitations in Diagnosing Tumors

By MedImaging International staff writers
Posted on 11 Sep 2023
Print article
Image: Simple contrast ultrasound scan resolves indeterminate MR and CT (Photo courtesy of Freepik)
Image: Simple contrast ultrasound scan resolves indeterminate MR and CT (Photo courtesy of Freepik)

Contrast-enhanced ultrasound (CEUS) takes traditional ultrasound imaging up a notch and is widely applied globally for diagnosing heart conditions and assessing the risk of heart attacks or strokes. CEUS also plays a role in identifying and assessing tumors in various organs like the liver, kidney, prostate, and breast, as well as in tracking the efficacy of cancer treatments. Unlike other imaging techniques, CEUS employs non-radioactive ultrasound contrast agents, also known as UCAs or UEAs, to enhance the quality and reliability of standard ultrasound images. The high-resolution, real-time images produced by CEUS often match the quality of those obtained from CT or MR scans. Moreover, ultrasound equipment is not only less costly than other diagnostic imaging tools like MRIs and CTs but is also portable, readily available, and can be taken directly to a patient's bedside if necessary.

CEUS can also be an invaluable resource for clarifying ambiguous MR and CT scan results, according to Dr. Stephanie Wilson, a clinical professor of radiology and gastroenterology at the University of Calgary (Alberta, Canada) and Co-President of the International Contrast Ultrasound Society (ICUS, Chicago, IL, USA). The ultrasound contrast agents used in CEUS consist of suspensions of tiny injectable "microbubbles" that pose no known risk of kidney damage, brain contrast deposit, or ionizing radiation exposure for patients and healthcare providers alike. These microbubbles remain within blood vessels and do not go into the tissue, thereby offering highly accurate blood flow details when compared to interstitial agents used in CT and MR imaging. This level of detail in blood flow is vital for diagnosing and characterizing tumors as well as for detecting recurrences post-treatment, she noted.

“CEUS often overcomes limitations of MR and CT in diagnosing many tumors and detecting their recurrence,” said Dr. Wilson. “CEUS scans are significantly less expensive than MR and CT.”

“In addition, in cystic neoplasms anywhere in the body, including the liver, small deposits of tumor are detected on high resolution CEUS with superior sensitivity when compared to MR, which doesn’t even show the nodule or blood flow,” Dr. Wilson added. “Further, for liver imaging, CEUS overcomes MR limitations associated with fat and iron.”

Related Links:
University of Calgary 
ICUS 

Gold Supplier
128 Slice CT Scanner
Supria 128
Gold Supplier
Conductive Gel
Tensive
New
X-Ray Flat Panel Detector
VIVIX-S 1751S
New
Portable DR Flat Panel Detector
VIVIX-S 1012N

Print article
Sun Nuclear -    Mirion

Channels

Radiography

view channel
Image: The AI model improves tumor removal accuracy during breast cancer surgery (Photo courtesy of UNC School of Medicine)

AI Model Analyzes Tumors Removed Surgically in Real-Time

During breast cancer surgery, the surgeon removes the tumor, also known as a specimen, along with a bit of the adjacent healthy tissue to ensure all cancerous cells are excised. This specimen is then X-rayed... Read more

MRI

view channel
Image: MRI screen-detected breast cancers have been found to be most often invasive cancers (Photo courtesy of 123RF)

MRI Screen-Detected Breast Cancers Are Mostly Invasive

Annual breast MRI screening is advised for patients with a lifetime breast cancer risk exceeding 20%. There exists robust data about the features of mammographic screen-detected breast cancers, although... Read more

Nuclear Medicine

view channel
Image: An AI model can evaluate brain tumors on PET (Photo courtesy of Freepik)

AI Model for PET Imaging Determines Patient Response to Brain Tumor Treatments

The assessment of changes in metabolic tumor volume (MTV) through PET scans using specific radiotracers like F-18 fluoroethyl tyrosine (FET) plays a vital role in evaluating the treatment response in patients... Read more

General/Advanced Imaging

view channel
Image: Annalise Enterprise CTB acts like a ‘second pair of eyes’ for radiologists (Photo courtesy of Annalise.ai)

Deep Learning System Boosts Radiologist Accuracy and Speed for Head CTs

Non-contrast computed tomography of the brain (NCCTB) is a commonly employed method for identifying intracranial pathology. Despite its frequent use, the complex scan outcomes are prone to being misunderstood.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.